NO981386L - Stimulering av celle-medierte immunresponser ved mÕls÷kt partikkelformig genetisk immunisering - Google Patents

Stimulering av celle-medierte immunresponser ved mÕls÷kt partikkelformig genetisk immunisering

Info

Publication number: NO981386L
Authority: NO; Norway
Prior art keywords: stimulation; cell; immune responses; mediated immune; particular genetic
Prior art date: 1995-09-28

Application number

NO981386A

Other languages

English (en)

Norwegian (no)

Other versions

NO981386D0 (no

Inventor

Louis D Falo Jr

Kenneth L Rock

Original Assignee

Univ Pittsburgh

Dana Farber Cancer Inst Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-28

Filing date

1998-03-26

Publication date

1998-05-28

1998-03-26 Application filed by Univ Pittsburgh, Dana Farber Cancer Inst Inc filed Critical Univ Pittsburgh

1998-03-26 Publication of NO981386D0 publication Critical patent/NO981386D0/no

1998-05-28 Publication of NO981386L publication Critical patent/NO981386L/no

Links

230000002068 genetic effect Effects 0.000 title 1
230000003053 immunization Effects 0.000 title 1
238000002649 immunization Methods 0.000 title 1
230000021633 leukocyte mediated immunity Effects 0.000 title 1
230000000638 stimulation Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001192—Glycoprotein 100 [Gp100]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001148—Regulators of development
- A61K39/00115—Apoptosis related proteins, e.g. survivin or livin
- A61K39/001151—Apoptosis related proteins, e.g. survivin or livin p53
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00118—Cancer antigens from embryonic or fetal origin
- A61K39/001182—Carcinoembryonic antigen [CEA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001191—Melan-A/MART
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Immunology (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pregnancy & Childbirth (AREA)
Developmental Biology & Embryology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
AIDS & HIV (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

NO981386A 1995-09-28 1998-03-26 Stimulering av celle-medierte immunresponser ved mÕls÷kt partikkelformig genetisk immunisering NO981386L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53555695A	1995-09-28	1995-09-28
PCT/US1996/015728 WO1997011605A1 (fr)	1995-09-28	1996-09-27	Stimulation de reponses immunes cellulaires par une imunisation genique ciblee utilisant un agent particulaire

Publications (2)

Publication Number	Publication Date
NO981386D0 NO981386D0 (no)	1998-03-26
NO981386L true NO981386L (no)	1998-05-28

Family

ID=24134735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO981386A NO981386L (no)	1995-09-28	1998-03-26	Stimulering av celle-medierte immunresponser ved mÕls÷kt partikkelformig genetisk immunisering

Country Status (15)

Country	Link
EP (1)	EP0863704A4 (fr)
JP (1)	JPH11512724A (fr)
KR (1)	KR19990063672A (fr)
CN (1)	CN1201369A (fr)
AU (1)	AU716497B2 (fr)
BG (1)	BG102355A (fr)
CA (1)	CA2233278A1 (fr)
CZ (1)	CZ92998A3 (fr)
HU (1)	HUP9802651A3 (fr)
NO (1)	NO981386L (fr)
NZ (1)	NZ319891A (fr)
PL (1)	PL325953A1 (fr)
SK (1)	SK40198A3 (fr)
TR (1)	TR199800573T2 (fr)
WO (1)	WO1997011605A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997044446A1 (fr) *	1996-05-24	1997-11-27	University Of Maryland At Baltimore	Vaccins d'adn induisant une immunoreaction des muqueuses
TW570803B (en) *	1997-04-09	2004-01-11	Duphar Int Res	Influenza vaccine
US6287569B1 (en) *	1997-04-10	2001-09-11	The Regents Of The University Of California	Vaccines with enhanced intracellular processing
AU3291099A (en) *	1998-02-11	1999-08-30	Maxygen, Inc.	Genetic vaccine vector engineering
US7390619B1 (en)	1998-02-11	2008-06-24	Maxygen, Inc.	Optimization of immunomodulatory properties of genetic vaccines
AU2487300A (en)	1998-12-31	2000-07-31	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en)	1998-12-31	2000-07-31	Chiron Corporation	Improved expression of hiv polypeptides and production of virus-like particles
JP2002542264A (ja) *	1999-04-21	2002-12-10	パウダージェクトヴァクシンズ，インコーポレイテッド	核酸による免疫化
JP4430868B2 (ja)	2001-03-30	2010-03-10	ジーエイチシーリサーチディベロップメントコーポレイション	単球に特異的な粒子性送達媒体
EP1411770A4 (fr)	2001-07-05	2006-05-10	Chiron Corp	Polynucleotides codant des polypeptides de type c du vih antigeniques, polypeptides et leurs utilisations
US20030170614A1 (en)	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US11529414B2 (en)	2020-06-23	2022-12-20	Orbis Health Solutions, Llc	Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same

1996
- 1996-09-27 TR TR1998/00573T patent/TR199800573T2/xx unknown
- 1996-09-27 CA CA002233278A patent/CA2233278A1/fr not_active Abandoned
- 1996-09-27 WO PCT/US1996/015728 patent/WO1997011605A1/fr not_active Ceased
- 1996-09-27 HU HU9802651A patent/HUP9802651A3/hu unknown
- 1996-09-27 JP JP9513762A patent/JPH11512724A/ja active Pending
- 1996-09-27 SK SK401-98A patent/SK40198A3/sk unknown
- 1996-09-27 CN CN96198106A patent/CN1201369A/zh active Pending
- 1996-09-27 NZ NZ319891A patent/NZ319891A/xx unknown
- 1996-09-27 CZ CZ98929A patent/CZ92998A3/cs unknown
- 1996-09-27 EP EP96933987A patent/EP0863704A4/fr not_active Withdrawn
- 1996-09-27 KR KR1019980702134A patent/KR19990063672A/ko not_active Ceased
- 1996-09-27 AU AU72515/96A patent/AU716497B2/en not_active Ceased
- 1996-09-27 PL PL96325953A patent/PL325953A1/xx unknown
1998
- 1998-03-26 NO NO981386A patent/NO981386L/no unknown
- 1998-03-26 BG BG102355A patent/BG102355A/xx unknown

Also Published As

Publication number	Publication date
HUP9802651A2 (hu)	1999-02-01
AU7251596A (en)	1997-04-17
CN1201369A (zh)	1998-12-09
EP0863704A4 (fr)	2003-09-10
SK40198A3 (en)	1998-11-04
WO1997011605A1 (fr)	1997-04-03
NZ319891A (en)	1999-01-28
CA2233278A1 (fr)	1997-04-03
HUP9802651A3 (en)	2001-08-28
EP0863704A1 (fr)	1998-09-16
AU716497B2 (en)	2000-02-24
CZ92998A3 (cs)	1998-09-16
NO981386D0 (no)	1998-03-26
TR199800573T2 (xx)	1998-07-21
JPH11512724A (ja)	1999-11-02
PL325953A1 (en)	1998-08-17
BG102355A (bg)	1999-04-30
KR19990063672A (ko)	1999-07-26

Publication	Publication Date	Title
ZA9811501B (en)	2000-06-15	Method to enhance an immune response of nucleic acid vaccination.
NO981386L (no)	1998-05-28	Stimulering av celle-medierte immunresponser ved mÕls÷kt partikkelformig genetisk immunisering
NO964713L (no)	1997-05-09	DNA-basert vaksinering av fisk ved immersjon
NO961483D0 (no)	1996-04-12	Fremgangsmåte for behandling av oljeholdig formasjon
NO965107D0 (no)	1996-11-29	Katalysatorer på kobberbasis, fremgangsmåte for fremstilling derav samt anvendelse av katalysatorene og fremgangsmåte for fremstilling av alkylhalogensilaner
NO986177D0 (no)	1998-12-29	FremgangsmÕte for fremstilling av terapeutisk DNA
FI973484A7 (fi)	1997-10-24	Menetelmä immuunivasteen stimuloimiseksi
ITBO940153A0 (it)	1994-04-12	Metodo per il controllo ottico di prodotti.
NO973193D0 (no)	1997-07-09	Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
HK1015223A (en)	1999-10-15	Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
KR960033768U (ko)	1996-11-19	스치로폴절단기의 열선고정구
KR970044493U (ko)	1997-07-31	팬히터의 안전망 구조
GB9503008D0 (en)	1995-04-05	Method of enhancing immune responses
HK1032196A (en)	2001-07-13	Method to enhance an immune response of nucleic acid vaccination
ITTO950021V0 (it)	1995-01-31	Presentatore di prodotti per esercizi commerciali.
IL117305A0 (en)	1996-06-18	Gene therapy of atherosclerosis by genetically modified monocytes
KR960036493U (ko)	1996-12-16	단조물의 열간 코잉장치
UA25747A (uk)	1998-12-25	Спосіб одержаhhя формоваhих виробів
KR960037407U (ko)	1996-12-16	제품의 쿠션부재
ITMO920059A1 (it)	1993-10-24	Dispositivo distributore di prodotti, oggetti e manufatti, particolarmente adatto per apparecchi distributori
SE9503073D0 (sv)	1995-09-07	Metod för uppvärmning av byggnader
KR960029380U (ko)	1996-09-17	난방기기의 물끓임대
IT240295Y1 (it)	2001-03-26	Alzata per monoporzioni di dolci e prodotti gastronomici
UA25109A (uk)	1998-12-25	Спосіб створюваhhя холедоходуодеhоаhастомозу
SE9500164D0 (sv)	1995-01-19	Mellanrumstandborsta av cirkulär form